Sunday, December 13, 2020 5:20:51 PM
Just letting you know that the oral fluid drug testing platform has been available throughout 2020. The decline in the need for drug testing put the "introduction" and the "sales" of this product on the back burner. As companies have settled into a new work flow during the pandemic, drug test sales have been slowly increasing, but are not near pre-pandemic levels.
Most importantly the new oral drug platform was the test the company was relying on to increase sales from the previous years of poor performance. So getting the word out and introducing it to the world is definitely helpful.
As far as announcing new clients or contracts for in house manufacturing, we will never hear about them. It was only gleaned through an email that the contracts can take months to a year to come to fruition. So even if the deals negotiations began in 2019, they are not old news. It is possible manufacturing has just recently commenced.
Of course, new manufacturing contracts are always welcomed. These type of contracts are difficult to gain due to very, very, heavy overseas competition, so if a contract is signed, it should be valuable to bottom line sales.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM